About NOX
Noxopharm Limited (NOX) is a clinical-stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to improve the safety profile of a range of mRNA medicines. The company utilises in house capabilities and strategic partnerships with researchers to build a growing pipeline of new proprietary drugs based on two technology platforms - Sofra (inflammation, autoimmunity, mRNA drug enhancement, and oncology) and Chroma (oncology).
Find out what a historical investment in Noxopharm would be worth today using our NOX stock calculator.
Market Capitalisation
$18.74M
Price-earnings ratio
-4.00
Dividend yield
-
High today
$0.06
Low today
$0.06
Open price
$0.06
52-week high
$0.11
52-week low
$0.05
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NOX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in NOX on Stake
- Buy NOX from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
NOX related stocks